Journal of Medical Internet Research

View query in Help articles search

Field

e.g. mhealth

Operator

Field

Criteria

e.g. John Smith or 0000-0001-6479-5330

Exact Match for Criteria

Yes No

Search Results (1 to 10 of 1802 Results)

Download search results: CSV END BibTex RIS

Sort by:

Effect of a Tailored eHealth Physical Activity Intervention on Physical Activity and Depression During Postpartum: Randomized Controlled Trial (The Postpartum Wellness Study)

Sylvia E Badon, Nina Oberman, Maya Ramsey, Charles P Quesenberry, Elaine Kurtovich, Lizeth Gomez Chavez, Susan D Brown, Cheryl L Albright, Mibhali Bhalala, Lyndsay A Avalos

JMIR Ment Health 2025;12:e64507

Download Citation: END BibTex RIS

Download PDF Download XML

Domain-Specific Evaluation of Exergame Metrics Among Older Adults With Mild Neurocognitive Disorder: Secondary Analysis of 2 Randomized Controlled Trials

Wanda Kaiser, Eling D de Bruin, Patrick Manser

JMIR Serious Games 2025;13:e65878

Download Citation: END BibTex RIS

Download PDF Download XML

Evaluating the Acceptability and Utility of a Personalized Wellness App (Aspire2B) Using AI-Enabled Digital Biomarkers: Engagement Enhancement Pilot Study

Calissa J Leslie-Miller, Shellen R Goltz, Pamela L Barrios, Christopher C Cushing, Teena Badshah, Corey T Ungaro, Shankang Qu, Yulia Berezhnaya, Tristin D Brisbois

JMIR Form Res 2025;9:e63471

Download Citation: END BibTex RIS

Download PDF Download XML

Combining Artificial Intelligence and Human Support in Mental Health: Digital Intervention With Comparable Effectiveness to Human-Delivered Care

Clinical effectiveness was quantified by calculating the change in anxiety symptoms, measured using the GAD-7, from baseline to final score, and estimating a within-participant effect size (Cohen d). A negative mean change denotes a reduction in GAD-7 total scores. Absolute Cohen d values are presented. The threshold for a clinically meaningful reduction in symptoms was defined as a change greater than the reliable change index of the GAD-7 scale (minimum of a 4-point reduction) [54].

Clare E Palmer, Emily Marshall, Edward Millgate, Graham Warren, Michael Ewbank, Elisa Cooper, Samantha Lawes, Alastair Smith, Chris Hutchins-Joss, Jessica Young, Malika Bouazzaoui, Morad Margoum, Sandra Healey, Louise Marshall, Shaun Mehew, Ronan Cummins, Valentin Tablan, Ana Catarino, Andrew E Welchman, Andrew D Blackwell

J Med Internet Res 2025;27:e69351

Download Citation: END BibTex RIS

Download PDF Download XML

Nonpharmacological Multimodal Interventions for Cognitive Functions in Older Adults With Mild Cognitive Impairment: Scoping Review

0.71, P=.002; MMSE: η2=0.189, P=.001) ME (ACE: Cohen d=0.64, P=.007; AVLT: η2=0.173, P=.001) PS (DRT-II: η2=0.033, P=.11) VF (Cohen d=0.73, P=.001) HEaq ATT (TMT-A and TMT-B) GC (ADAS-Cog and KMMSEar) PS (DSST) Group×time interaction ATT—TMT-A: P GC (ADAS-Cog: P=.11); KMMSE (P=.72) PS (P=.02) CT only EF (EFPT-Kas and FABat) EF (EFPT-K: η2=0.132, P CT only PT only SA only ATT (VFT-Category) GC (ADAS-Cog, CDR-SOBau, and CMMSEav) ME (list learning delayed recall test) ATT (VFT-C: χ2=23.38, P GC (ADAS-Cog: χ2=3.31

Raffy Chi-Fung Chan, Joson Hao-Shen Zhou, Yuan Cao, Kenneth Lo, Peter Hiu-Fung Ng, David Ho-Keung Shum, Arnold Yu-Lok Wong